1He J, Whelton PK, Vu B, eta!. Aspirin and risk of hemorr- hagic stroke: a meta-analysis of randomized controlled trials [J]. JAMA, 1998, 280(22): 1930-1935.
2Ohwaki K, Yano E, Nagashima H, et al. Blood pressure management in acute intraeerebral hemorrhage: relation- ship between elevated blood pressure and hematoma enlargement [J]. Stroke, 2004, 35(6): 1364-1367.
3Alderson CS, Huang Y, Wang JG, eta!. Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial [J]. Lancet Neurol, 2008, 7(5): 391- 399.
4Cucchiara B, Messe S, Sansing L, et al. Hematoma growth in oral anticoagulant related intracerebral hemorrhage [J]. Stroke, 2008, 39(11): 2993-2996.
5Ishibashi A, Yokokura Y, Adachi H. Is antiplatelet therapy for the prevention of ischemic stroke associated with the prognosis of intracerebral hemorrhage [J]? Kurume Med J, 2008, 55(3-4): 71-75.
6Lauer A, Schlunk F, Van Cott EM, et al. Antiplatelet pretreatment does not increase he matoma volume inexperimental intracerebral hemorrhage [J]. J Cereb Blood Flow Metab, 2011, 31(8): 1736-1742.
7Naidech AM, Bendok BR, Garg RK, et al. Reduced platelet activity is associated with more intraventricular hemorrhage [J]. Neurosurgery, 2009, 65(4): 684-688.
9Biondi-Zoccai GG, Lotrionte M, Agostoni P, et d. A sys- tematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50, 279 patients at risk for coronary artery disease [J]. Eur Heart J, 2006, 27(22): 2667-2674.
